1,123 results on '"Macintyre, Elizabeth"'
Search Results
2. Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL
3. Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma
4. Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma
5. ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development
6. Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial
7. TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
8. Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL
9. Clonotype definitions for immunogenetic studies: proposals from the EuroClonality NGS Working Group
10. Multimodal cartography of human lymphopoiesis reveals B and T/NK/ILC lineages are subjected to differential regulation
11. Distinct subsets of multi-lymphoid progenitors support ontogeny-related changes in human lymphopoiesis
12. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma
13. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia
14. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
15. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
16. DNA methylation as a new tool for the differential diagnosis between T‐LBL and lymphocyte‐rich thymoma.
17. A vision to the future: value-based laboratory medicine.
18. Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols
19. Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients
20. Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
21. One-Step Next-Generation Sequencing of Immunoglobulin and T-Cell Receptor Gene Recombinations for MRD Marker Identification in Acute Lymphoblastic Leukemia
22. Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis
23. Adenylate kinase 2 expression and addiction in T-ALL
24. Precision hematology:Navigating the evolution of diagnostic classifications in the era of globalized medicine
25. Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract
26. Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
27. Supplementary Figure S1 from PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax
28. Supplementary Table S2 from PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax
29. Data from PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax
30. A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis
31. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins
32. CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm
33. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
34. Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study
35. Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation
36. Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma
37. Optical Genome Mapping Provides New Molecular Insights in High-Risk Mantle Cell Lymphoma: A Lysa Study
38. Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia
39. Rôle du pathologiste dans le diagnostic de la maladie cœliaque et de ses complications
40. Loss of ARHGEF1 causes a human primary antibody deficiency
41. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
42. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
43. S108: ATP CITRATE LYASE IS AN ESSENTIAL PLAYER OF THE METABOLIC REWIRING INDUCED BY PTEN LOSS DURING T-ALL DEVELOPMENT
44. P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
45. P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
46. PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
47. Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.
48. Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia
49. Supplementary Figures 1 - 3, Table 1 from Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia
50. Data from Novel Intergenically Spliced Chimera, NFATC3-PLA2G15, Is Associated with Aggressive T-ALL Biology and Outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.